Alaunos Therapeutics (TCRT) Financials: Revenue & Earnings

TCRT price $2.13 +0.07 +3.40%

Ticker
TCRT
Price
$2.13
Change
+0.07 +3.40%
Market cap ?
$6.23M
P/E ?
-0.98
Dividend yield ?
0.00%
Beta ?
-0.97
Sector
Healthcare
Industry
Biotechnology

Financials

2016201720182019202020212022202320242025
686100063890001460000039800029220005000100005000

Alaunos Therapeutics, Inc. is an oncology company in the clinical trial phase, specializing in the creation of adoptive T-cell receptor (TCR) engineered therapies. Their pipeline includes a TCR Library, currently undergoing Phase I/II clinical trials, which comprises ten T-cell receptors designed to target mutated KRAS, TP53, and EGFR in various cancers such as non-small cell lung, colorectal, endometrial…

Fair value

TCRT fair value Not meaningful. Price $2.13.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare TCRT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-17—-15.75——
2026-08-14-0.41———
2026-05-15-0.59———
2026-03-31-0.40-3.693.00K3.00K
2025-11-14-0.55-4.90——
2025-08-14-0.63-5.33——
2025-05-15-0.67-6.442.00K—
2025-03-31-0.46-4.504.00K—
2024-11-14-0.70-4.50——
2024-08-14-0.71-4.504.00K—
2024-05-15-1.10-4.501.00K—
2024-04-02-0.49-0.451.00K—
2023-11-14-6.00-4.50——
2023-08-14-6.00-6.004.00K—
2023-05-10-6.00-0.04——
2023-03-07-6.00-13.4911.00K—
2022-11-14-6.00-17.992.91M—
2022-08-15-7.50-16.49——
2022-05-16-7.50-13.49——
2022-03-30-7.50-13.49——
2021-11-08-0.11-0.13398.00K—
2021-08-13-0.11-0.12——
2021-05-06-0.10-0.10——
2021-02-25-0.11-0.10——
2020-11-05-0.10-0.09——
2020-08-06-0.09-0.09——
2020-05-07-0.09-0.08——
2020-04-29-13.16———
2019-11-07-0.43-0.09——
2019-08-08-0.09-0.08——
2019-05-08-0.08-0.08——
2019-03-05-0.08-0.11——
2018-11-09-0.13-0.11——
2018-08-08-0.12-0.12——
2018-05-10-0.15-0.13146.00K—
2018-04-30-14.16—1.60M—
2017-11-06-0.13-0.141.60M—
2017-07-31-0.13-0.131.60M—
2017-05-01-0.14-0.121.60M—
2017-02-16-0.11-0.111.60M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-13Fairmount Funds Management LLCOther0——
2026-10-13Fairmount Funds Management LLCOther105.29M——
2026-10-13Fairmount Funds Management LLCOther16.73M——
2026-10-06Weis HolgerBuy23.56K$0.7417.54K
2026-10-06Vieser JaimeBuy22.67K$0.7416.87K
2026-10-06Postma Robert WBuy21.83K$0.7416.25K
2026-10-06Jerman Michael AllenBuy20.99K$0.7415.62K
2026-08-06Weis HolgerBuy4.36K$2.018.77K
2026-07-23Jerman Michael AllenBuy8.14K$1.9215.62K
2026-07-23Weis HolgerBuy4.57K$1.928.77K
2026-07-23Postma Robert WBuy8.46K$1.9216.25K
2026-07-23Vieser JaimeBuy8.79K$1.9216.87K
2026-06-30Weis HolgerBuy3.88K$2.268.77K
2026-06-12Weis HolgerBuy7.76K$2.2617.54K
2026-05-22Weis HolgerBuy3.70K$2.378.77K
2026-04-29Vieser JaimeBuy6.51K$2.5916.87K
2026-04-29Postma Robert WBuy6.27K$2.5916.25K
2026-04-29Jerman Michael AllenBuy6.03K$2.5915.62K
2026-01-12Jerman Michael AllenBuy5.41K$2.8915.62K
2026-01-12Postma Robert WBuy5.62K$2.8916.25K
2026-01-12Vieser JaimeBuy5.84K$2.8916.87K
2025-11-21Vieser JaimeBuy5.34K$3.1616.87K
2025-11-21Postma Robert WBuy5.14K$3.1616.25K
2025-11-21Jerman Michael AllenBuy4.18K$3.1613.22K
2025-08-18Groenewald FerdinandBuy10.78K——
2025-08-18Groenewald FerdinandBuy4.00K$2.329.28K
2025-08-18Weis HolgerBuy13.68K$2.3231.73K
2025-07-15Jerman Michael AllenBuy10.00K$3.4034.00K
2025-07-15Jerman Michael AllenBuy3.20K$3.4010.88K
2025-07-15Jerman Michael AllenOther0——
2025-07-03Postma Robert WBuy4.05K——
2025-07-03Postma Robert WBuy6.40K$5.0032.00K
2025-07-03Vieser JaimeBuy3.40K——
2025-07-03Vieser JaimeBuy6.40K$5.0032.00K
2025-07-02Weis HolgerBuy130.00K$5.02652.60K
2025-06-24Vieser JaimeBuy250$4.491.12K
2025-06-24Postma Robert WBuy600$4.492.69K
2025-04-13Postma Robert WBuy20.80K$2.9260.75K
2025-04-13Weis HolgerBuy10.90K$2.9231.84K
2025-04-13Vieser JaimeBuy17.46K——
2025-04-11Postma Robert WBuy500$2.761.38K
2025-03-29Hogue Dale Curtis Jr.Buy3.00K$1.464.38K
2025-03-29Lackey MelindaBuy1.00K$1.461.46K
2025-03-29Groenewald FerdinandBuy3.00K$1.464.38K
2024-12-31Vieser JaimeSell2.18K$2.014.39K
2024-12-31Vieser JaimeSell818$2.001.64K
2024-08-14Groenewald FerdinandBuy1.50K$2.423.63K
2024-08-14Lackey MelindaBuy1.50K$2.423.63K
2024-06-06Weis HolgerBuy19.20K$1.0319.78K
2024-06-06Weis HolgerBuy4.52K$1.034.66K
2024-06-06Vieser JaimeBuy12.80K$1.0313.18K
2024-06-06Postma Robert WBuy12.80K$1.0313.18K
2024-06-06Hofmeister RobertBuy12.80K$1.0313.18K
2024-02-22Groenewald FerdinandOther0——
2024-01-20Hogue Dale Curtis Jr.Buy600.00K$0.1272.00K
2023-12-29Hogue Dale Curtis Jr.Buy150.00K$0.0710.65K
2023-12-29Hogue Dale Curtis Jr.Buy41.67K$0.072.96K
2023-12-29Hogue Dale Curtis Jr.Other0——
2023-09-01Boyle Kevin S. Sr.Sell68.01K$0.149.54K
2023-06-06Postma Robert WBuy100.00K$0.4848.00K
2023-06-06Hofmeister RobertBuy100.00K$0.4848.00K
2023-06-06Thistle MaryBuy100.00K$0.4848.00K
2023-06-06Huang JamesBuy100.00K$0.4848.00K
2023-06-06Vieser JaimeBuy100.00K$0.4848.00K
2023-06-06Weis HolgerBuy100.00K$0.4848.00K
2023-03-30Hofmeister RobertBuy150.00K$0.6699.00K
2023-03-30Hofmeister RobertBuy16.67K$0.6611.00K
2023-03-30Hofmeister RobertOther0——
2023-03-15Srivastava Abhishek KBuy125.00K$0.5062.50K
2023-03-15Wong MichaelBuy125.00K$0.5062.50K
2023-03-15Boyle Kevin S. Sr.Buy1.80M$0.50900.00K
2023-03-15Deniger DrewBuy125.00K$0.5062.50K
2023-03-15Lackey MelindaBuy200.00K$0.50100.00K
2022-11-29Postma Robert WBuy750.00K$0.65487.50K
2022-11-29Vieser JaimeBuy1.25M$0.65812.50K
2022-09-15Deniger DrewBuy305.00K$2.11643.55K
2022-09-15Srivastava Abhishek KBuy25.00K$2.1152.75K
2022-09-15Wong MichaelBuy50.00K$2.11105.50K
2022-09-15Lackey MelindaBuy185.00K$2.11390.35K
2022-08-30Boyle Kevin S. Sr.Sell18.75K$2.4145.19K
2022-08-12Srivastava Abhishek KBuy250.00K——
2022-08-03Srivastava Abhishek KSell0——
2022-06-22Thistle MaryBuy100.00K$0.8282.00K
2022-06-22Thistle MaryBuy100.00K——
2022-06-22Huang JamesBuy100.00K——
2022-06-22Postma Robert WBuy100.00K——
2022-06-22Thistle MaryBuy40.00K——
2022-06-22Huang JamesBuy80.00K——
2022-06-22Postma Robert WBuy40.00K——
2022-06-22Postma Robert WBuy100.00K$0.8282.00K
2022-06-22Vieser JaimeBuy100.00K——
2022-06-22Bowden ChristopherBuy100.00K——
2022-06-22Weis HolgerBuy100.00K——
2022-03-30Boyle Kevin S. Sr.Buy2.00M——
2022-03-30De Groot EleanorBuy350.00K$0.66231.00K
2022-03-30De Groot EleanorBuy350.00K——
2022-03-29Deniger DrewSell0——
2022-03-29Deniger DrewSell75.00K$2.82211.50K
2022-03-29Deniger DrewSell50.00K$4.13206.50K
2022-03-29Deniger DrewSell30.00K$4.72141.60K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 30, holders +1 vs prior quarter. Ownership 3.72%.

HolderSharesChangeChange %Value
BLACKROCK, INC.21.35K00.00%48.26K
GEODE CAPITAL MANAGEMENT, LLC19.36K-3.20K-14.20%43.75K
VANGUARD FIDUCIARY TRUST CO15.50K00.00%35.02K
VANGUARD CAPITAL MANAGEMENT LLC14.06K00.00%31.78K
CITADEL ADVISORS LLC11.87K1.35K+12.84%26.83K
OSAIC HOLDINGS, INC.1.73K-48-2.70%3.91K
TOWER RESEARCH CAPITAL LLC (TRC)1.62K38+2.40%3.66K
ARAX ADVISORY PARTNERS1.22K1.22KNew2.75K
UBS GROUP AG992-1.28K-56.38%2.24K
MORGAN STANLEY836183+28.02%1.89K
VANGUARD GLOBAL ADVISERS, LLC50100.00%1.13K
ROYAL BANK OF CANADA375190+102.70%1.00K
WELLS FARGO & COMPANY/MN388198+104.21%877
BLUE TRUST, INC.13500.00%305
STEWARD PARTNERS INVESTMENT ADVISORY, LLC11220+21.74%253
FEDERATION DES CAISSES DESJARDINS DU QUEBEC7000.00%158
BOKF, NA6666New149
AXIOM INVESTMENT MANAGEMENT LLC4646New104
MERCER GLOBAL ADVISORS INC /ADV3838New86
KEY FINANCIAL INC2400.00%54
SIGNATUREFD, LLC2300.00%52
NFSG CORP2100.00%47
LANARK FINANCIAL, INC.2000.00%45
ADVISORNET FINANCIAL, INC1900.00%43
BARCLAYS PLC1515New34

Earnings and financials

Alaunos Therapeutics, Inc. (TCRT) trades at $2.13, with a market cap of $6.23M and a trailing P/E of -0.98. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
686100063890001460000039800029220005000100005000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Alaunos Therapeutics (TCRT) Financials: Revenue & Earnings

TCRT$2.13+0.07 +3.40%

$6.23M

Market Cap

-0.98

P/E

—

Forward P/E

—

Score

Price History